Search

everythinglearnresearchcommunity

for

Search:↓

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Chestnut flower extract may help reduce prostate cancer growth.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Most patients improved with oral contraceptives, but some needed additional treatment.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Cimetidine did not reduce hair growth in women with hirsutism.

Some birth control pills can cause temporary or more serious hair loss.

Trigonelline nanocrystal cream effectively promotes hair growth and may reduce side effects.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Sunlight exposure increases drug toxicity; amber glass best for protection.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

French maritime pine bark extract significantly increased hair density in menopausal women.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Denosumab may cause alopecia areata.